Summary
In a significant market movement during July 2021, Artios was the subject of a vc funding. The transaction achieved a gross valuation of £110,770,186. Leading the round was CaaS Capital Management, Omega Funds, Tetragon Financial Group Limited, Schroders Capital, Piper Heartland Healthcare Capital, Avidity Partners, Sofinnova Partners, Soleus Capital, Invus, Deep Track Capital, TCG X, RTW Investments LP.
This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.
Lead Investor / Acquirer
CaaS Capital Management
Lead Investor / Acquirer
Omega Funds
Lead Investor / Acquirer
Tetragon Financial Group Limited
Lead Investor / Acquirer
Schroders Capital
Lead Investor / Acquirer
Piper Heartland Healthcare Capital
Lead Investor / Acquirer
Avidity Partners
Lead Investor / Acquirer
Sofinnova Partners
Lead Investor / Acquirer
Soleus Capital
Lead Investor / Acquirer
Invus
Lead Investor / Acquirer
Deep Track Capital
Lead Investor / Acquirer
TCG X
Lead Investor / Acquirer
RTW Investments LP
Advising Broker
Undisclosed Firm
Related Deals in Healthcare & Biotech
Series C prioritisedOriginal Source
This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.
View on Tech.eu Funding ExplorerFunding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.
AI Insight Lenses
ProAI-generated analysis from four professional perspectives. Powered by PE Deals.
Sign in to unlock AI Lenses
Sign in